PF-07292554

N/A

Report date: 2025/01/26 16:03:14
NME

Base Information

Drug NamePF-07292554
Drug Alias NameeIF4E inhibitors (eFFECTOR Therapeutics/Pfizer)eukaryotic initiation factor 4E inhibitors (eFFECTOR Therapeutics/Pfizer)eIF4E inhibitors (eFFECTOR Therapeutics/Pfizer)eukaryotic initiation factor 4E inhibitors (eFFECTOR Therapeutics/Pfizer)eukaryotic initiation factor 4E inhibitors (eFFECTOR Therapeutics) +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEukaryotic translation initiation factor 4E inhibitors
TargetsEukaryotic translation initiation factor 4E
Therapy Area/IndicationsSolid tumoursBreast NeoplasmsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEffector Therapeutics Operations Inc
China Registration ClassN/A

Develop Information

Active CompaniesEffector Therapeutics Operations IncPfizer Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursBreast Neoplasms
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A